Inclusion body myositis long after dermatomyositis: A report of two cases

Clinical and Experimental Rheumatology

Volumn 17, Issue 2, 1999, Pages 235-239

  McCoy, A L ^a   Bubb, M R ^a   Plotz, Paul H ^a,b   Davis, J C ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Autoimmunity; Dermatomyositis; Inclusion body myositis; Inflammatory myopathy; Polymyositis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HUMAN; INCLUSION BODY MYOSITIS; MALE; MUSCLE BIOPSY; PATHOGENESIS; POLYMYOSITIS; PRIORITY JOURNAL;

ADULT; AZATHIOPRINE; CREATINE KINASE; DERMATOMYOSITIS; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; PREDNISOLONE;

EID: 0032966210     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. STAHL NI, KLIPPEL JH, DECKER JL: A cutaneous lesion associated with myositis. Ann Intern Med 1979; 91: 577-9.
2. ENGEL AG, HOHLFELD R, BANKER BQ: The polymyositis and dermatomyosilis syndromes. In ENGEL AG and FRANZINI-ARMSTRONG C (Eds.): Myology. 2nd ed., New York, McGraw-Hill, Inc. 1994: 1355-83.
3. CASADEMONT J, GRAU JM, MASANES F, HERRERO C, URBANO-MARQUEZ A: Analysis of the outcome of idiopathic inflammatory myopathies with particular empllasis on muscle capillary damage. Scand J Rheumatol 1993; 22: 292-8.
4. ENGEL AG, ARAHATA K: Mononuclear cells in myopathies: Quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 1986; 17: 704-21.
5. KARPATI G, POULIOT Y, CARPENTER S: Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 1988; 23: 64-72,
6. EMSLIE-SMITH AM, ARAHATA K, ENGEL AG: Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 1989; 20: 224-31.
7. MILLER FW, LOVE LA, BARBIERI SA, BALOW JE, PLOTZ PH: Lymphocyte activation markers in idiopathic myositis: Changes with disease activity and differences among clinical and autoantibody subgroups. Clin Exp Immunol 1990; 81: 373-89.
8. RINGEL SP, FORSTOT JZ, TAN EM, WEHLING C, GRIGGS RC, BUTCHER D: Sjögren's syndrome and polymyositis or dermatomyositis. Arch Neurol 1982: 39: 157-63.
9. GRAN JT, MYKLEBUST G: The concomitant occurrence of Sjögren's syndrome and polymyositis. Scand J Rheumatol 1992;21: 150-4.
10. KRAUS A, CABALLERO-URIBE C, JAKEZ J, VILLA AR, ALARCON-SEGOVIA D: Raynaud's phenomenon in primary Sjögren's syndrome. Association with other extraglandular manifestations. J Rheumatol 1992; 19: 1572-4.
11. LOVE LA, LEFF RL, FRASER DD et al.: A new approach to the classifiaction of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991; 70: 360-74.
12. GRIGGS RC, ASKANAS V, DIMAURO S et al.: Inclusion body myositis and myopathies. Ann Neurol 1995; 38: 705-13.
13. COLE AJ, KUZNIECKY R, KARPATI G, CARPENTER S, ANDERMANN E, ANDERMANN F: Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy. A new syndrome. Brain 1988; 111: 1025-37.
14. MASSA R, WELLER B, KARPATI G, SHOUBRIDGE E, CARPENTER S: Familial inclusion body myositis among Kurdish-Iranian Jews. Arch Neurol 1991; 48: 519-22.
15. KOFFMAN BM, RUGIERO M, DALAKAS MC: Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis. Muscle Nerve 1998; 21: 115-7.
16. LANE RJM, FULTHORPE JJ, HUDGSON P: Inclusion body myositis: a case with associated collagen vascular disease responding to treatment. J Neurol Neurosurg Psychiatry 1985; 48: 270-3.
17. MENDELL JR, SAHENK Z, GALES T, PAUL L: Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments. Arch Neurol 1991; 48; 1229-34.
18. ODDIS CV, CONTE CG, STEEN VD, MEDSGER TA JR: Incidence of polymyositis-dermatomyositis: A 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol 1990; 17: 1329-34.
19. LOTZ BP, ENGEL AG, NISHINO H, STEVENS JC, LITCHY WJ: Inclusion body myositis. Observations in 40 patients. Brain 1989; 112: 727-47.
20. ABARBANEL JM, LICHTENFELD Y, ZIRKIN H et al.: Inclusion body myositis in post-poliomyelitis muscular atrophy. Acta Neurol Scand 1988; 78: 81-4.
21. EISEN A, BERRY K, GIBSON G: Inclusion body myositis (IBM): Myopathy or neuropathy? Neurology 1983; 33: 1109-14.
22. DALAKAS MC: The post-polio syndrome as an evolved clinical entity. Definition and clinical description. Ann NYAcad Sci 1995; 753:68-80: 68-80.
23. RIGGS JE, SCHOCHET SS JR, GUTMANN L, LERFALD SC: Childhood onset inclusion body myositis mimicking limb-girdle muscular dystrophy. J Child Neurol 1989; 4: 283-5.
24. HUGHES JT, ESIRI MM: Ultrastructural studies in human polymyositis. J Neurol 1975; 25: 347-60.
25. SALAMA J, TOME FM, LEBON P, MARIE L, DELAPORTE P, FARDEAU M: [Inclusion body myositis: Clinical, morphological and virological study of a new case associated with scleroderma and Klinefelter's syndrome (author's transl.)]. Rev Neurol (Paris) 1980; 136: 863-78.
26. CHAD D, GOOD P, ADELMAN L, BRADLEY WG, MILLS J: Inclusion body myositis associated with Sjögren's syndrome. Arch Neurol 1982; 39: 186-8.
27. RIGGS JE, SCHOCHET SS JR, GUTMANN L, MCCOMAS CF, ROGERS JS 2d: Inclusion body myositis and chronic immune thrombocytopenia. Arch Neurol 1984; 41: 93-5.
28. GOTMANN L, GOVINDAN S, RIGGS JE, SCHOCHET SS: Inclusion body myositis and Sjögren's syndrome. Arch Neurol 1985; 42: 1021-2.
29. YOOD RA, SMITH TW: Inclusion body myositis and systemic lupus erythematosus, J Rheumatol 1985; 12: 568-70.
30. AVERBUCH-HELLER L, STEINER I, ABRAMSKY O: Neurologic manifestations of progressive systemic sclrosis. Arch Neurol 1992: 49: 1292-5.
31. DE BLEECKER JL, ENGEL AG: Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies. Am J Pathol 1995; 146: 1178-87.
32. ENGELAG, ARAHATA K: Monoclonal antibody analysis of mononuclear cells in myopathies II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984; 16: 209-15.